CapForce Inc.
Healthcare · Services-Medical Laboratories · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $30.2M | $5.2M | $3.4M | $2.6M | $4.3M | $4.2M |
| Operating income | $24.0M | $324,717 | −$30.7M | −$34.6M | −$23.3M | −$22.7M |
| Net income | $23.6M | $12.0M | −$32.7M | −$37.3M | −$34.8M | −$26.2M |
| Total assets | $38.1M | $9.9M | $1.9M | $25.8M | $71.7M | $49.8M |
| Total liabilities | $6.2M | $2.5M | $13.4M | $18.2M | $30.4M | $28.6M |
| Equity | $31.9M | $7.4M | −$11.6M | $7.6M | $41.2M | $21.2M |
| EPS (diluted) | $2.32 | $2.30 | $-41.47 | $-152.70 | $-22.89 | — |
| Shares out. | 10.1M | 1.3M | 5.5M | 46.6M | 38.3M | 11.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 79.6%
- Net margin
- 78.2%
- Return on equity
- 74.1%
- Return on assets
- 62.1%
- Return on capital (ROCE)
- 71.7%
- Liabilities / assets
- 16.3%
- Debt / equity
- 0.19×
- Book value / share
- $3.16
- Revenue growth (YoY)
- 481.2%
- Net income growth (YoY)
- 97.0%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -14.09distress
- Accruals / assets
- 65.2%high accruals
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 2 warning● 4 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- High accruals — earnings-quality risk
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2026
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2026
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2025
- NT 10-Qmissed a reporting deadline ↗May 16, 2025
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2025
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Tan HonjianActivist (13D)Oct 24, 2024
- Tg Investment Ltd.Passive (13G)Sep 24, 2024
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Material events
SEC Form 8-K · most recent- Director / officer change · Amended charter or bylaws · Shareholder vote · Regulation FD disclosureFeb 27, 2026
- Entered a material agreement · Completed an acquisition or dispositionJan 16, 2026
- Entered a material agreement · Unregistered equity sale · Director / officer changeDec 23, 2025
- Director / officer changeDec 5, 2025
- Director / officer changeJul 22, 2025
- Entered a material agreementMay 29, 2025
- Delisting / listing-standard noticeDec 27, 2024
- Director / officer changeDec 6, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.